These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 377673)

  • 21. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of leukocyte migration, complement fixing antibodies and fibrinogen fibrin split products in the urine of patients after cadaver kidney transplantation].
    Drannik GN; Baran EIa
    Urol Nefrol (Mosk); 1978; (3):18-21. PubMed ID: 351908
    [No Abstract]   [Full Text] [Related]  

  • 23. Daily immunologic tests in the prediction of renal transplant rejection.
    Wood RF; Gray AC; Bell PR
    Transplant Proc; 1978 Sep; 10(3):593-4. PubMed ID: 362640
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T; Kaneko S; Iguchi M; Minami K; Kadowaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):599-608. PubMed ID: 335137
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dynamics of the immunological and blood coagulation indices in experimental kidney allotransplantation].
    Drannik GN
    Urol Nefrol (Mosk); 1978; (2):48-51. PubMed ID: 347665
    [No Abstract]   [Full Text] [Related]  

  • 26. A new and sensitive method to detect acute rejection in renal transplantation.
    Kano T; Orihara A; Morozumi K; Uchida K; Yamada N; Tominaga Y; Kawai M; Takagi H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1691-4. PubMed ID: 3547877
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of determination of factor VIII-related antigen in glomerular disease].
    Dong DC
    Zhonghua Yi Xue Za Zhi; 1982 Jul; 62(7):404-6. PubMed ID: 6816412
    [No Abstract]   [Full Text] [Related]  

  • 28. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM; Sherman LA; Valdes AJ; Lubowitz H
    J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIII-related antigen determination in glomerular disease.
    Wang HL; Chen SJ; Zhang LN; Zhi LM; Dong DC; Chen QR; Zhou HZ
    Chin Med J (Engl); 1983 Feb; 96(2):117-20. PubMed ID: 6406168
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
    Kunikata S; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretion rate of antithrombin III related antigen in cerebral stroke.
    Matsuo T; Shinomiya K; Okuno S; Matsuo C; Matsuo O
    Thromb Haemost; 1984 Dec; 52(3):305-7. PubMed ID: 6442470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine.
    Morozumi K; Kano T; Kobayashi M; Shinmura I; Yoshida A; Fujinami T; Otaguro K; Uchida K; Yamada N; Tominaga Y
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1791-4. PubMed ID: 3547884
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic degradation products in urine of anticoagulated transplant patients.
    Aguilo JJ; Bowie EJ; Woods JE; Owen CA
    Eur Urol; 1978; 4(1):46-9. PubMed ID: 342250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proceedings: Hypercoagulability and compensated intravascular coagulation in chronic kidney insufficiency and after kidney transplantation].
    Bachmann F; Ing TS; Sagartz S
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1771-3. PubMed ID: 766178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.